Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
354 Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): long-term efficacy and safety update from a phase 1b/2 study
Compose a Response to This Article
Other responses
No responses have been published for this article.